Citation Tools

Download PDFPDF
Research paper
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events

Download to a citation manager

Cite this article as:
Calabrese M, Pitteri M, Farina G, et al
Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events